compounded semaglutide law Legal Insights into Peptide and Compounding Compounded Semaglutide (GLP-1) Injections |

Non-oral contraception or backup contraceptive methods are recommended for 4 weeks after initiation and with each dose increase

Increasing access will require addressing the significant barriers to care, such as treatment cost, site of care, and the policies that insurance plans can implement, such as step therapy and prior authorizations. For the study, the team used national insurance claims data for more than 97,000 commercially insured US adults diagnosed with obesity, but not diabetes, between June 2021 and July 2022

For weight management specifically, comparisons should reference the higher 2.4 mg dose of semaglutide (Wegovy) rather than the 1 mg dose used for diabetes

El, K., & Campbell, J

Blood testing is recommended for GLP-1 users to monitor metabolic changes, weight loss progress, and potential side effects such as blood sugar fluctuations

The shift in size demand, coupled with the need for new inventory, can have significant financial implications for retailers